Institutional Ownership Dyne Therapeutics, Inc. (DYN)
This table provides information about the institutional ownership of Dyne Therapeutics, Inc. (DYN). We have compiled data on the 217 institutions that hold shares in the stock, with a total of 116 Million shares, which have been reported (via 13F filing form) to have a value of $1.09 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Janus Henderson Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
10,353,416
shares
|
$97.3 Million
0.06% of portfolio
|
Q1 2025
Added 40.3%
|
|
|
Ra Capital Management, L.P.
Boston, MA |
May 15, 2025 Q1 2025 |
9,714,392
shares
|
$91.3 Million
2.11% of portfolio
|
Q1 2025
Added 52.24%
|
|
|
Atlas Venture Life Science Advisors, LLC
|
May 14, 2025 Q1 2025 |
9,130,465
shares
|
$85.8 Million
27.97% of portfolio
|
Q1 2025
Added 13.86%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
7,406,344
shares
|
$69.6 Million
0.0% of portfolio
|
Q1 2025
Added 10.48%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,386,988
shares
|
$69.4 Million
0.01% of portfolio
|
Q2 2024
Added 37.05%
|
|
|
Fcpm Iii Services B.V.
Naarden, P7 |
May 15, 2025 Q1 2025 |
5,462,846
shares
|
$51.4 Million
13.81% of portfolio
|
Q4 2024
Reduced 8.25%
|
|
|
Braidwell LP
Stamford, CT |
May 15, 2025 Q1 2025 |
3,621,344
shares
|
$34 Million
2.32% of portfolio
|
Q1 2025
Added 431.63%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
3,609,651
shares
|
$33.9 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.9%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
3,009,389
shares
|
$28.3 Million
0.01% of portfolio
|
Q1 2025
Added 5.17%
|
|
|
Armistice Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
2,768,000
shares
|
$26 Million
0.44% of portfolio
|
Q1 2025
Added 186.98%
|
|
|
Siren, L.L.C.
New York, NY |
May 14, 2025 Q1 2025 |
2,717,987
shares
|
$25.5 Million
1.62% of portfolio
|
Q1 2025
Added 101.71%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
May 14, 2025 Q1 2025 |
2,650,150
shares
|
$24.9 Million
6.68% of portfolio
|
Q1 2024
Added 60.6%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
2,531,313
shares
|
$23.8 Million
0.0% of portfolio
|
Q1 2025
Added 2472.81%
|
|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
2,313,403
shares
|
$21.7 Million
1.01% of portfolio
|
Q1 2025
Added 325.82%
|
|
|
Vr Adviser, LLC
New York, NY |
May 15, 2025 Q1 2025 |
2,173,913
shares
|
$20.4 Million
5.49% of portfolio
|
Q2 2023
New holding
|
|
|
Deep Track Capital, LP
Greenwich, CT |
May 15, 2025 Q1 2025 |
2,000,000
shares
|
$18.8 Million
0.73% of portfolio
|
Q4 2024
Reduced 39.06%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,955,505
shares
|
$18.4 Million
0.0% of portfolio
|
Q1 2025
Added 3.61%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
1,820,415
shares
|
$17.1 Million
0.0% of portfolio
|
Q1 2025
Reduced 24.23%
|
|
|
Vestal Point Capital, LP
New York, NY |
May 15, 2025 Q1 2025 |
1,800,000
shares
|
$16.9 Million
1.34% of portfolio
|
Q1 2025
New holding
|
|
|
Rtw Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
1,690,567
shares
|
$15.9 Million
0.29% of portfolio
|
Q1 2025
Reduced 67.61%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
May 15, 2025 Q1 2025 |
1,528,534
shares
|
$14.4 Million
0.04% of portfolio
|
Q1 2025
Added 65.3%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
1,443,341
shares
|
$13.6 Million
0.95% of portfolio
|
Q1 2025
New holding
|
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2025 Q1 2025 |
1,414,835
shares
|
$13.3 Million
0.0% of portfolio
|
Q1 2025
Added 6.88%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
1,391,587
shares
|
$13.1 Million
0.0% of portfolio
|
Q1 2025
Added 84.66%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
May 15, 2025 Q1 2025 |
1,388,425
shares
|
$13.1 Million
0.06% of portfolio
|
Q1 2025
Added 1066.6%
|